A multicenter study to assess the cholesterol lowering level of switching to an investigational drug compared to doubling the dose of an investigational drug in patients with hypercholesterolemia and atherosclerotic or coronary vascular disease.
Phase of Trial: Phase III
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Atorvastatin
- Indications Atherosclerosis; Coronary disorders; Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 22 Oct 2005 New trial record.